Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-042927
Filing Date
2014-06-20
Accepted
2014-06-20 17:29:32
Documents
1
Period of Report
2014-06-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4026
  Complete submission text file 0001209191-14-042927.txt   5492
Mailing Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Issuer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
EMANUELE ROBERT MARTIN (Reporting) CIK: 0001184991 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32157 | Film No.: 14933660